 |
Heptadecasodium salt of an 18-base residue phosphorothioate oligonucleotide |
|---|---|
| Trade Name | |
| Orphan Indication | Spinal muscular atrophy |
| USA Market Approval | USA |
| USA Designation Date | 2011-04-18 00:00:00 |
| Sponsor | Isis Pharmaceuticals, Inc.;1896 Rutherford Road;Carlsbad, CA, 92008 |
Related Access Program
Pfizer – Non Small Cell Lung Cancer With ALK or ROS1 Rearrangement
Pfizer – Non Small Cell Lung Cancer Harboring Molecular Alterations
Biogen – Infantile-onset Spinal Muscular Atrophy
Novartis Pharmaceuticals – Non-small Cell Lung Cancer (NSCLC)
Biogen – Infantile-onset Spinal Muscular Atrophy (SMA)